semaglutide dosing 2.5mg/ml FDA alerts health care providers, compounders and patients of errors associated with compounded injectable products GLP-1 Semaglutide Rx | FancyMeds

Who can get it: A Mounjaro Rx requires a diagnosis of type 2 diabetes

Common adverse effects include: Nausea (reported by 30-40% of patients at the 2.4 mg dose) Vomiting Diarrhea Constipation Abdominal pain Decreased appetite These gastrointestinal symptoms are typically most pronounced during dose escalation and often improve with continued treatment

Glucagon-like peptide-1 receptor agonists in the perioperative period: Implications for the anaesthesiologist

It's a great question

It binds to long-chain fatty acyl groups and ferries them through the carnitine palmitoyltransferase (CPT-1 and CPT-2) enzyme system into the mitochondrial matrix, where beta-oxidation converts them into acetyl-CoA and ultimately ATP

The ideal candidate is a patient who has hit a hard plateau on a GLP-1 receptor agonist and complains of significant fatigue or lethargy